Smith Asset Management Group LP acquired a new position in shares of Flamel Technologies SA (NASDAQ:FLML) during the second quarter, Holdings Channel reports. The institutional investor acquired 29,780 shares of the company’s stock, valued at approximately $320,000.
Other large investors have also modified their holdings of the company. Acadian Asset Management LLC increased its stake in shares of Flamel Technologies SA by 240.2% in the second quarter. Acadian Asset Management LLC now owns 1,617,223 shares of the company’s stock worth $17,372,000 after buying an additional 1,141,783 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Flamel Technologies SA by 10.7% in the first quarter. JPMorgan Chase & Co. now owns 316,992 shares of the company’s stock worth $3,499,000 after buying an additional 30,760 shares during the last quarter. Opus Point Partners Management LLC increased its stake in shares of Flamel Technologies SA by 21.7% in the first quarter. Opus Point Partners Management LLC now owns 69,109 shares of the company’s stock worth $763,000 after buying an additional 12,321 shares during the last quarter. Finally, Bogle Investment Management L P DE increased its stake in shares of Flamel Technologies SA by 2,270.4% in the first quarter. Bogle Investment Management L P DE now owns 269,044 shares of the company’s stock worth $2,970,000 after buying an additional 257,694 shares during the last quarter. 70.33% of the stock is owned by hedge funds and other institutional investors.
Shares of Flamel Technologies SA (NASDAQ:FLML) traded down 2.69% during mid-day trading on Tuesday, reaching $13.00. 282,839 shares of the company’s stock traded hands. The company has a market cap of $536.13 million, a P/E ratio of 31.48 and a beta of 1.42. The company’s 50 day moving average is $13.75 and its 200 day moving average is $11.75. Flamel Technologies SA has a 12-month low of $7.56 and a 12-month high of $19.78.
Flamel Technologies SA (NASDAQ:FLML) last posted its quarterly earnings results on Monday, August 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.06 by $0.08. The company earned $38.90 million during the quarter, compared to analysts’ expectations of $32.80 million. Flamel Technologies SA had a return on equity of 25.19% and a net margin of 12.11%. The company’s quarterly revenue was down 20.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.34 EPS. On average, analysts predict that Flamel Technologies SA will post ($1.08) EPS for the current fiscal year.
A number of equities research analysts have recently issued reports on FLML shares. Zacks Investment Research raised shares of Flamel Technologies SA from a “sell” rating to a “hold” rating in a research report on Tuesday, July 12th. Leerink Swann restated an “outperform” rating and set a $16.00 target price on shares of Flamel Technologies SA in a research note on Tuesday. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $18.63.
In other Flamel Technologies SA news, CEO Michael S. Anderson acquired 5,000 shares of the business’s stock in a transaction dated Monday, August 22nd. The shares were purchased at an average price of $14.30 per share, for a total transaction of $71,500.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Francis Fildes sold 15,000 shares of the stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $13.45, for a total transaction of $201,750.00. Following the completion of the sale, the director now owns 15,000 shares in the company, valued at approximately $201,750. The disclosure for this sale can be found here. 4.45% of the stock is currently owned by company insiders.
Flamel Technologies SA Company Profile
Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.
Want to see what other hedge funds are holding FLML? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Flamel Technologies SA (NASDAQ:FLML).
Receive News & Ratings for Flamel Technologies SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flamel Technologies SA and related companies with MarketBeat.com's FREE daily email newsletter.